Pharmaceuticals & Therapeutics

Iceland's Alvotech secured a crucial capital infusion. It's a high-stakes play to survive financial pressures and compete in the next wave of affordable medicine.

As Philip Morris International shuffles its top ranks, we look at the leaders tasked with realizing a controversial, yet lucrative, smoke-free future.

A new report projects the wellness market will hit $12.9T by 2031. This isn't just about yoga mats; it's a tech-fueled, Asia-led economic realignment.

A new power deal between Statkraft and Alcoa is more than a contract. It’s a deep look into a national strategy for securing industry in a volatile world.

As Destinus rolls out its 1,000th turbojet, a new era of European military self-sufficiency dawns, breaking a critical dependency in defense manufacturing.

Japan's century-old CALPIS drink is coming to India. It's a story not just of a new beverage, but of a strategic system designed to conquer a complex market.

A landmark Sino-Singaporean joint venture aims to tackle global water scarcity by merging advanced Chinese membrane tech with Singaporean market savvy.

As Oncoinvent accelerates its Phase 2 trial, a novel alpha-emitter therapy shows promise against a deadly cancer, signaling progress in radiopharmaceuticals.

South Korea's JNJ International is leveraging Automechanika Mexico to enter the lucrative Latin American aftermarket, a region ripe with aging vehicles.

URBANICA’s new Conference Chair isn't just furniture; it's a calculated move into the office's most neglected real estate—the collaborative space.

An Arkansas lab's $30 million settlement with the DOJ offers a rare look into 'lean lab' models and the fine line between business and patient care.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.

AXE's viral 'wiener man' wasn't just a gag. It was a calculated play for attention in the crowded World Cup market, redefining brand engagement.

Healthcare firm Cosmos Health is diversifying into the crowded skincare market with a DTC brand. Can its science-first approach disrupt the beauty industry?

A probiotic brand's $1M TikTok Shop event wasn't just a sales blitz. It's a calculated move proving social commerce is the new gateway to retail giants.

Allbirds' IP finds new life with licensing experts, while its former parent company sheds its footwear past to chase an AI future as 'Smartbird'.

A Michigan ear clinic's new partnership reveals a seismic shift in healthcare. Private equity and MSOs promise growth, but what does this mean for doctors?

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

Melanie Krinsky’s visionary approach to finance has funneled billions into entertainment, backing indie hits and reshaping how creativity gets funded.

AB Science has secured a US patent until 2042 for masitinib, a targeted therapy for advanced prostate cancer, offering new hope where few options exist.